136 related articles for article (PubMed ID: 26504030)
21. Simvastatin attenuates macrophage-mediated gemcitabine resistance of pancreatic ductal adenocarcinoma by regulating the TGF-β1/Gfi-1 axis.
Xian G; Zhao J; Qin C; Zhang Z; Lin Y; Su Z
Cancer Lett; 2017 Jan; 385():65-74. PubMed ID: 27840243
[TBL] [Abstract][Full Text] [Related]
22. Forced expression of heat shock protein 27 (Hsp27) reverses P-glycoprotein (ABCB1)-mediated drug efflux and MDR1 gene expression in Adriamycin-resistant human breast cancer cells.
Kanagasabai R; Krishnamurthy K; Druhan LJ; Ilangovan G
J Biol Chem; 2011 Sep; 286(38):33289-300. PubMed ID: 21784846
[TBL] [Abstract][Full Text] [Related]
23. Significance of unphosphorylated and phosphorylated heat shock protein 27 as a prognostic biomarker in pancreatic ductal adenocarcinoma.
Drexler R; Wagner KC; Küchler M; Feyerabend B; Kleine M; Oldhafer KJ
J Cancer Res Clin Oncol; 2020 May; 146(5):1125-1137. PubMed ID: 32200459
[TBL] [Abstract][Full Text] [Related]
24. Heterogeneous nuclear ribonucleoprotein K inhibits heat shock-induced transcriptional activity of heat shock factor 1.
Kim HJ; Lee JJ; Cho JH; Jeong J; Park AY; Kang W; Lee KJ
J Biol Chem; 2017 Aug; 292(31):12801-12812. PubMed ID: 28592492
[TBL] [Abstract][Full Text] [Related]
25. Triptolide cooperates with Cisplatin to induce apoptosis in gemcitabine-resistant pancreatic cancer.
Zhu W; Li J; Wu S; Li S; Le L; Su X; Qiu P; Hu H; Yan G
Pancreas; 2012 Oct; 41(7):1029-38. PubMed ID: 22617708
[TBL] [Abstract][Full Text] [Related]
26. Resistance to gemcitabine in the pancreatic cancer cell line KLM1-R reversed by metformin action.
Baron B; Wang Y; Maehara S; Maehara Y; Kuramitsu Y; Nakamura K
Anticancer Res; 2015 Apr; 35(4):1941-9. PubMed ID: 25862846
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of heat shock protein 27 (HSP27) increases gemcitabine sensitivity in pancreatic cancer cells through S-phase arrest and apoptosis.
Guo Y; Ziesch A; Hocke S; Kampmann E; Ochs S; De Toni EN; Göke B; Gallmeier E
J Cell Mol Med; 2015 Feb; 19(2):340-50. PubMed ID: 25331547
[TBL] [Abstract][Full Text] [Related]
28. A standardized extract of cultured
Islam S; Kitagawa T; Baron B; Kuhara K; Nagayasu H; Kobayashi M; Chiba I; Kuramitsu Y
Oncol Lett; 2021 Sep; 22(3):654. PubMed ID: 34386076
[TBL] [Abstract][Full Text] [Related]
29. OGX-427 inhibits tumor progression and enhances gemcitabine chemotherapy in pancreatic cancer.
Baylot V; Andrieu C; Katsogiannou M; Taieb D; Garcia S; Giusiano S; Acunzo J; Iovanna J; Gleave M; Garrido C; Rocchi P
Cell Death Dis; 2011 Oct; 2(10):e221. PubMed ID: 22012255
[TBL] [Abstract][Full Text] [Related]
30. Heat-shock protein 27 (HSP27, HSPB1) is up-regulated by MET kinase inhibitors and confers resistance to MET-targeted therapy.
Musiani D; Konda JD; Pavan S; Torchiaro E; Sassi F; Noghero A; Erriquez J; Perera T; Olivero M; Di Renzo MF
FASEB J; 2014 Sep; 28(9):4055-67. PubMed ID: 24903273
[TBL] [Abstract][Full Text] [Related]
31. Alleviating Effect of Active Hexose Correlated Compound (AHCC) on Chemotherapy-Related Adverse Events in Patients with Unresectable Pancreatic Ductal Adenocarcinoma.
Yanagimoto H; Satoi S; Yamamoto T; Hirooka S; Yamaki S; Kotsuka M; Ryota H; Michiura T; Inoue K; Matsui Y; Tsuta K; Kon M
Nutr Cancer; 2016; 68(2):234-40. PubMed ID: 26847832
[TBL] [Abstract][Full Text] [Related]
32. Heat shock protein 27 as a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma.
Schäfer C; Seeliger H; Bader DC; Assmann G; Buchner D; Guo Y; Ziesch A; Palagyi A; Ochs S; Laubender RP; Jung A; De Toni EN; Kirchner T; Göke B; Bruns C; Gallmeier E
J Cell Mol Med; 2012 Aug; 16(8):1776-91. PubMed ID: 22004109
[TBL] [Abstract][Full Text] [Related]
33. KRIBB11 inhibits HSP70 synthesis through inhibition of heat shock factor 1 function by impairing the recruitment of positive transcription elongation factor b to the hsp70 promoter.
Yoon YJ; Kim JA; Shin KD; Shin DS; Han YM; Lee YJ; Lee JS; Kwon BM; Han DC
J Biol Chem; 2011 Jan; 286(3):1737-47. PubMed ID: 21078672
[TBL] [Abstract][Full Text] [Related]
34. The maximal cytoprotective function of the heat shock protein 27 is dependent on heat shock protein 70.
Sreedharan R; Riordan M; Thullin G; Van Why S; Siegel NJ; Kashgarian M
Biochim Biophys Acta; 2011 Jan; 1813(1):129-35. PubMed ID: 20934464
[TBL] [Abstract][Full Text] [Related]
35. Heat Shock Protein 27 Expression in EUS-FNA Samples Can Predict Gemcitabine Sensitivity in Pancreatic Cancer.
Kawano M; Kaino S; Amano S; Shinoda S; Suenaga S; Sen-Yo M; Sakaida I
In Vivo; 2018; 32(3):637-642. PubMed ID: 29695571
[TBL] [Abstract][Full Text] [Related]
36. Identification of up- and down-regulated proteins in gemcitabine-resistant pancreatic cancer cells using two-dimensional gel electrophoresis and mass spectrometry.
Kuramitsu Y; Taba K; Ryozawa S; Yoshida K; Zhang X; Tanaka T; Maehara S; Maehara Y; Sakaida I; Nakamura K
Anticancer Res; 2010 Sep; 30(9):3367-72. PubMed ID: 20944110
[TBL] [Abstract][Full Text] [Related]
37. A novel association between the human heat shock transcription factor 1 (HSF1) and prostate adenocarcinoma.
Hoang AT; Huang J; Rudra-Ganguly N; Zheng J; Powell WC; Rabindran SK; Wu C; Roy-Burman P
Am J Pathol; 2000 Mar; 156(3):857-64. PubMed ID: 10702402
[TBL] [Abstract][Full Text] [Related]
38. Heat shock protein 25 or inducible heat shock protein 70 activates heat shock factor 1: dephosphorylation on serine 307 through inhibition of ERK1/2 phosphorylation.
Seo HR; Chung DY; Lee YJ; Lee DH; Kim JI; Bae S; Chung HY; Lee SJ; Jeoung D; Lee YS
J Biol Chem; 2006 Jun; 281(25):17220-17227. PubMed ID: 16624816
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of HIF-1α by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma.
Zhao T; Ren H; Jia L; Chen J; Xin W; Yan F; Li J; Wang X; Gao S; Qian D; Huang C; Hao J
Oncotarget; 2015 Feb; 6(4):2250-62. PubMed ID: 25544770
[TBL] [Abstract][Full Text] [Related]
40. Heat shock protein 27 is involved in SUMO-2/3 modification of heat shock factor 1 and thereby modulates the transcription factor activity.
Brunet Simioni M; De Thonel A; Hammann A; Joly AL; Bossis G; Fourmaux E; Bouchot A; Landry J; Piechaczyk M; Garrido C
Oncogene; 2009 Sep; 28(37):3332-44. PubMed ID: 19597476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
